Scandion Oncology
Overcoming cancer drug resistance

Navbar

About us
Research & Development
News & Press
- Press releases
- Media
  - Image library
  - Video library
Investors
Contact
- Career

Skip to content

19 November 2017

Poster presentation on November 1, 2017

Poster presentation on November 1, 2017, at the Biomarker AGORA 2017, Copenhagen, Denmark.

Posted in NewsTagged News

Post navigation

New Saniona spinout focused on cancer therapy

Abstracts and poster presentations on October 28, 2017

Frontpage
Press releases
Poster presentation on November 1, 2017

About us

About us
Executive Management
Board of Directors
Clinical Advisory Board

Research & Development

Research & Development
Pipeline
Clinical Development
Science

News & Press

Press releases
Other news
Media
- Image library items
- Video library items

Investors

Investors
Share information
Financial Reports
Presentations
Analyst Coverage
Prospectuses
Corporate governance
Events

Contact us

Scandion Oncology A/S
Symbion
Fruebjergvej 3
2100 Copenhagen
Denmark

Phone: +45 38 10 20 17
info@scandiononcology.com

Media and Investor relations:
Email: ir@scandiononcology.com
Phone: +45 29 60 35 32

Follow us

Scandion Oncology - The Cancer Drug Resistance Company

Our vision is to overcome cancer drug resistance in order to improve lives for cancer patients and their families

© Copyright 2022 - Scandion Oncology A/S | We use cookies to improve our services | Disclaimer: Market data could be delayed. Delivered by Cision.